Publications by authors named "Alessandro Limongelli"

Claim this Profile
Case Report: 12 Months Persisting Subcutaneous Nodule After Long-Acting Cabotegravir/Rilpivirine Administration.
Alessandro Limongelli, Giovanni Massobrio, Lucia Taramasso, Giulio Bovio, Marco Nofri

AIDS Patient Care STDS· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of echinocandins and liposomal amphotericin B for fluconazole-resistant bloodstream infections.
Antonio Vena, Claudia Bartalucci, Marco Muccio, Giusy Tiseo, Patricia Muñoz, Alessandro Limongelli

Antimicrob Agents Chemother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent candidemia caused by different Candida species: Data from a multicenter contemporary cohort.
Giusy Tiseo, Antonio Vena, Matteo Bassetti, Claudia Bartalucci, Matteo Cerchiaro, Alessandro Limongelli

J Infect· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rezafungin Utilisation in Real Life-FungiScope Results From Europe and the United States.
Ilana Reinhold, Giovanni Mori, Massimiliano Lanzafame, Alessandro Limongelli, Antonio Vena

Mycoses· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a molecular syndromic panel for the etiological diagnosis of ventilator-associated bacterial pneumonia: impact on clinical outcomes and antibiotic use from a multicenter, prospective study.
Daniele Roberto Giacobbe, Greta Cattardico, Claudia Bartalucci, Vincenzo Di Pilato, Marco Muccio, Alessandro Limongelli

Crit Care· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep Learning for the Early Diagnosis of Candidemia.
Daniele Roberto Giacobbe, Sabrina Guastavino, Anna Razzetta, Cristina Marelli, Sara Mora, Alessandro Limongelli

Infect Dis Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience.
Francesca Serapide, Riccardo Serraino, Luigi Spadafora, Marco Bernardi, Giorgia Brucci, Alessandro Limongelli

J Antimicrob Chemother· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neural networks for the prediction of bacterial and fungal infections: current evidence and implications.
Cristina Marelli, Daniele Roberto Giacobbe, Alessandro Limongelli, Sabrina Guastavino, Cristina Campi

J Chemother· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report.
Jon Salmanton-García, Francesco Marchesi, Milan Navrátil, Klára Piukovics, Maria Ilaria Del Principe, Alessandro Limongelli

Am J Hematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Fluconazole Resistance on the Outcomes of Patients With Candida parapsilosis Bloodstream Infections: A Retrospective Multicenter Study.
Antonio Vena, Giusy Tiseo, Marco Falcone, Claudia Bartalucci, Cristina Marelli, Alessandro Limongelli

Clin Infect Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry.
Tommaso Francesco Aiello, Jon Salmanton-Garcia, Francesco Marchesi, Barbora Weinbergerova, Andreas Glenthoj, Alessandro Limongelli

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies.
Margherita Bellucci, Federica Maria Bozzano, Chiara Castellano, Giampaola Pesce, Alessandro Beronio, Alessandro Limongelli

Front Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge.
Claudia Bartalucci, Alessandro Limongelli, Laura Ambra Nicolini, Marta Ponzano, Stefania Tigano

J Chemother· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi, Shaimaa El-Ashwah, Marcio Nucci, Alessandro Limongelli

Infection· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi, Shaimaa El-Ashwah, Marcio Nucci, Alessandro Limongelli

Infection· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
Jon Salmanton-García, Francesco Marchesi, Francesca Farina, Barbora Weinbergerová, Federico Itri, Alessandro Limongelli

EClinicalMedicine· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients.
Nadia Castaldo, Antonio Vena, Alessandro Limongelli, Daniele Roberto Giacobbe, Matteo Bassetti

Curr Opin Infect Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring.
Malgorzata Mikulska, Monica Melchio, Alessio Signori, Nadir Ullah, Franca Miletich, Alessandro Limongelli

J Antimicrob Chemother· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Pellegrino Musto, Jon Salmanton-García, Nicola Sgherza, Rui Bergantim, Francesca Farina, Alessandro Limongelli

Hematol Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings.
Giuseppe Rossi, Jon Salmanton-García, Chiara Cattaneo, Francesco Marchesi, Julio Dávila-Valls, Alessandro Limongelli

Int J Infect Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early diagnosis of candidemia with explainable machine learning on automatically extracted laboratory and microbiological data: results of the AUTO-CAND project.
Daniele Roberto Giacobbe, Cristina Marelli, Sara Mora, Sabrina Guastavino, Chiara Russo, Alessandro Limongelli

Ann Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry.
Jon Salmanton-García, Francesco Marchesi, Philipp Koehler, Barbora Weinbergerová, Natasa Čolović, Alessandro Limongelli

Int J Antimicrob Agents· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia.
Daniele Roberto Giacobbe, Sara Mora, Alessio Signori, Chiara Russo, Giorgia Brucci, Alessandro Limongelli

Diagnostics (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and emerging drug treatment strategies to tackle invasive community-associated methicillin-resistant (MRSA) infection: what are the challenges?
Antonio Vena, Nadia Castaldo, Laura Magnasco, Martina Bavastro, Alessandro Limongelli

Expert Opin Pharmacother· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression.
Antonio Vena, Luca Traman, Martina Bavastro, Alessandro Limongelli, Chiara Dentone

Vaccines (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis